- Home
- FTLF vs CCCC Comparison
FTLF vs CCCC Comparison
Compare FTLF & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTLF
- CCCC
- Stock Information
- Founded
- FTLF 2005
- CCCC 2015
- Country
- FTLF United States
- CCCC United States
- Employees
- FTLF 39
- CCCC N/A
- Industry
- FTLF Medicinal Chemicals and Botanical Products
- CCCC Biotechnology: Pharmaceutical Preparations
- Sector
- FTLF Health Care
- CCCC Health Care
- Exchange
- FTLF Nasdaq
- CCCC Nasdaq
- Market Cap
- FTLF 172.4M
- CCCC 160.1M
- IPO Year
- FTLF N/A
- CCCC 2020
- Fundamental
- Price
- FTLF $18.36
- CCCC $2.34
- Analyst Decision
- FTLF Strong Buy
- CCCC Strong Buy
- Analyst Count
- FTLF 2
- CCCC 4
- Target Price
- FTLF $23.00
- CCCC $8.50
- AVG Volume (30 Days)
- FTLF 16.8K
- CCCC 2.1M
- Earning Date
- FTLF 11-13-2025
- CCCC 11-06-2025
- Dividend Yield
- FTLF N/A
- CCCC N/A
- EPS Growth
- FTLF N/A
- CCCC N/A
- EPS
- FTLF 0.80
- CCCC N/A
- Revenue
- FTLF $63,053,000.00
- CCCC $30,108,000.00
- Revenue This Year
- FTLF $34.34
- CCCC N/A
- Revenue Next Year
- FTLF $48.58
- CCCC N/A
- P/E Ratio
- FTLF $22.94
- CCCC N/A
- Revenue Growth
- FTLF 3.91
- CCCC N/A
- 52 Week Low
- FTLF $9.83
- CCCC $1.09
- 52 Week High
- FTLF $20.98
- CCCC $6.25
- Technical
- Relative Strength Index (RSI)
- FTLF 43.04
- CCCC 45.73
- Support Level
- FTLF $19.10
- CCCC $2.24
- Resistance Level
- FTLF $19.95
- CCCC $2.46
- Average True Range (ATR)
- FTLF 0.49
- CCCC 0.20
- MACD
- FTLF -0.07
- CCCC -0.01
- Stochastic Oscillator
- FTLF 27.75
- CCCC 18.55
About FTLF FitLife Brands Inc.
FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Isatori, and Biogenetic laboratories brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.